Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case repor... by Bloomer, Chance H., Gavrila, Elena, Burcher, Kimberly M., Kalada, John M., Chang, Mark J., Gebeyehu, Rediet R., Asare, Elsabeth, Khoury, Lara M., Kinney, Rebecca, Frizzell, Bart, Sullivan, Christopher A., Bunch, Paul M., Porosnicu, Mercedes

Get full text

Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer by Burcher, Kimberly M, Bloomer, Chance H, Gavrila, Elena, Kalada, John M, Chang, Mark J, Gebeyehu, Rediet R, Song, Alexander H, Khoury, Lara M, Lycan, Thomas W, Kinney, Rebecca, D'Agostino, Jr, Ralph, Bunch, Paul M, Shukla, Kirtikar, Triozzi, Pierre, Furdui, Cristina M, Zhang, Wei, Porosnicu, Mercedes

Get full text

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case repor... by Bloomer, Chance H, Gavrila, Elena, Burcher, Kimberly M, Kalada, John M, Chang, Mark J, Gebeyehu, Rediet R, Asare, Elsabeth, Khoury, Lara M, Kinney, Rebecca, Frizzell, Bart, Sullivan, Christopher A, Bunch, Paul M, Porosnicu, Mercedes

Get full text

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer by Hughes, Ryan T, Gebeyehu, Rediet R, Kalada, John Mason, Lycan, Thomas W, Frizzell, Bart A, Kinney, Rebecca D, D'Agostino, Ralph B, Bunch, Paul M, Triozzi, Pierre, Zhang, Wei, Furdui, Cristina M, Porosnicu, Mercedes

Get full text

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea by Bergenstal, Richard, Lewin, Andrew, Bailey, Timothy, Chang, Denise, Gylvin, Titus, Roberts, Victor

Get full text